DarioHealth Corp (NAS:DRIO)
$ 0.92 -0.0502 (-5.17%) Market Cap: 28.82 Mil Enterprise Value: 36.51 Mil PE Ratio: 0 PB Ratio: 0.41 GF Score: 62/100

Q1 2024 DarioHealth Corp Earnings Call Transcript

May 15, 2024 / 12:30PM GMT
Release Date Price: $1.85 (+6.94%)

Key Points

Positve
  • DarioHealth Corp (DRIO) reported substantial growth in its core B2B2C business channel, which now accounts for about 71% of the company's performance revenues for the quarter.
  • The company has achieved a SaaS-like gross margin above 75% in its B2B2C channel, which is expected to exceed 80%, indicating strong profitability potential.
  • DarioHealth Corp (DRIO) has successfully integrated acquisitions, leading to operational efficiencies and a faster-than-expected path to profitability, with cost synergies progressing ahead of schedule.
  • The company has secured significant contracts with major national health plans and employers, such as Cigna, Aetna, Amazon, Google, and Microsoft, which are expected to drive future revenue growth.
  • DarioHealth Corp (DRIO) is leveraging its extensive data collection from millions of users to enhance product offerings and potentially monetize through IP licensing or strategic transactions.
Negative
  • The company's strategic B2B revenue stream, which mainly involves pharma partners, is milestone-based and less predictable, with quarterly revenues showing variability.
  • Despite overall growth, the B2C business channel generated only $2 million in the quarter, indicating limited growth in this segment.
  • There are ongoing risks and uncertainties associated with the integration of acquisitions, which could impact future operational efficiencies and cost savings.
  • The company's reliance on a few large contracts and partners could pose risks if any key relationships are disrupted or underperform.
  • DarioHealth Corp (DRIO) faces intense competition in the digital health market, which could affect its market share and pressure pricing strategies.
Operator

Good morning, ladies and gentlemen, and welcome to the Dario Health first quarter 2024 Results Conference Call. (Operator Instructions) this call is being recorded on Wednesday, May 15, 2024.

I would now like to turn the conference over to Kat Parrella, Investor Relations Manager at Dario. Please go ahead.

Kat Parrella
DarioHealth Corp - Investor Relations

Thank you, operator, and good morning, everybody. Thank you for joining us today for a discussion of Dario Health First Quarter 2024 financial results. Leading the call today will be Erez Raphael CEO; of Dario Health, who will be joined by Rick Anderson, President and Dario health. After the prepared remarks, we will open the call for Q&A.

An audio recording and webcast replay for today's call will also be available online as detailed in the press release invite for this call for the benefit of those who may be listening to the replay or archived webcast this call is being held on Wednesday, May 15, 2024.

This morning, we issued a press release announcing our financial

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot